A new report finds that radiological imaging in cardiac stress testing is
overused; cutting back could reduce health costs and future cancer cases.
by John
Tyburski
Copyright © Daily
Digest News, KPR Media, LLC. All rights reserved.
AUTHOR’S
NOTE: The authors of the published research report contacted me directly to
request news coverage.
Technology
has advanced modern medicine but at a cost, both to health care expenditures
and to a patient’s long-term health status. For example, imaging techniques
that use radiation to provide glimpses of internal structures offer minimally
invasive approaches to finding health issues. However, they also expose
patients to a small doses of ionizing radiation, including the kind used in
X-rays and CT scans, which, in rare cases, can cause cancer down the road.
A team of
researchers led by assistant professor Joseph Ladapo of New York University’s
Departments of Medicine and Population Health examined whether the trade-offs
specifically associated with cardiac stress testing were being adequately
considered in decisions to include imaging. They found, in fact, that imaging
may be overused, creating unnecessary health care spending and increased risk
of cancer in those tested. The results of their study were published
in the October 8 issue of the Annals of Internal Medicine.
“The key
finding of our study is that cardiac stress testing with imaging has grown
briskly over the past two decades in the US, and that about 1 million stress
tests with imaging are probably inappropriate,” states Ladapo. “These
inappropriate tests cost us about half a billion dollars in healthcare costs
annually and lead to about 500 people developing cancer in their lifetime
because of radiation they received during that cardiac stress test.”
Cardiac
stress tests assess the amount of stress one’s heart can tolerate before it
exhibits signs of overburden such as abnormal rhythm or inadequate blood flow
within itself. Tests with imaging include the injection of a radioactive tracer
into the blood. The tracer emits small amounts of radiation that is then imaged
in order to identify areas of compromised blood flow.
Ladapo and
colleagues used data on patients with no coronary heart disease who were
referred for cardiac stress testing, gathered from the National Ambulatory
Medical Care Survey and the National Hospital Ambulatory Medical Care Survey.
They compared the number of stress tests ordered with and without imaging in
the period 1993 to 1995 with the number with and without imaging in the period
2008 to 2010.
The
researchers found that the annual number of cardiac stress tests ordered in the
U.S. increased by over 50 percent from 1993–1995 and 2008–2010 and attribute
this increase to changes in population and provider characteristics. Cardiac
stress tests with imaging comprised 59 percent of the total tests in 1993–1995
compared to 87 percent in 2008–2010. By referencing the most recent appropriate use criteria,
the researchers determined that 34.6 percent of the tests done with imaging in
2008–2010 really did not warrant imaging.
Using published methods,
the researchers estimate that this overuse of imaging in the period 2008–2010
cost $501 million. They predict, again based on published methods, that 491 future
cancer cases will be attributable to inappropriate imaging with cardiac stress
testing done in this period.
“Cardiac
stress testing is an important clinical tool,” says Dr. Ladapo, “but we are
over using imaging for reasons unrelated to clinical need.”
The report
comes quickly on the heels of a recent scientific statement
by the American Heart Association on improving informed decisions that involve
both doctors and patients when it comes to radiation-based imaging. Ladapo and
his colleagues also looked for but found no evidence that patient ethnicity
plays any significant role in whether a cardiac stress test with imaging is
ordered.